Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0000907654-26-000118

Chief Medical Officer sold 7,000 shares at an average $100.96 ($706,700)

  • Chief Medical Officer acquired 7,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Goncalves Joana Chief Medical Officer 2026-11-16 Option exercise 10b5-1 +3,500 $6.84 $23,940 35,271 D: show line 1 in the form
Goncalves Joana Chief Medical Officer 2026-11-16 Option exercise 10b5-1 +3,500 $7.80 $27,300 38,771 D: show line 2 in the form
Goncalves Joana Chief Medical Officer 2026-11-16 Sale 10b5-1 −2,600 $99.52 $258,739 36,171 D: show line 3 in the form
Goncalves Joana Chief Medical Officer 2026-11-16 Sale 10b5-1 −1,500 $100.48 $150,719 34,671 D: show line 4 in the form
Goncalves Joana Chief Medical Officer 2026-11-16 Sale 10b5-1 −1,900 $101.53 $192,901 32,771 D: show line 5 in the form
Goncalves Joana Chief Medical Officer 2026-11-16 Sale 10b5-1 −300 $102.47 $30,741 32,471 D: show line 6 in the form
Goncalves Joana Chief Medical Officer 2026-11-16 Sale 10b5-1 −200 $103.36 $20,672 32,271 D: show line 7 in the form
Goncalves Joana Chief Medical Officer 2026-11-16 Sale 10b5-1 −500 $105.86 $52,928 31,771 D: show line 8 in the form
Open-market sales · 7,000 sh · avg $100.96 · $706,700

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Goncalves Joana Chief Medical Officer 2026-11-16 Option exercise · Employee Stock Option (right to buy) 10b5-1 −3,500 186,563 D: show line 9 in the form
Goncalves Joana Chief Medical Officer 2026-11-16 Option exercise · Employee Warrant (right to buy) 10b5-1 −3,500 157,992 D: show line 10 in the form
Loading xslF345X06/form4.xml…